Abstract |
The highly selective glycogen synthase kinase-3 (GSK-3) inhibitor N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea (AR-A014418) was radiolabeled with carbon-11 ((11)C; half-life=20.4min) at the urea moiety via [(11)C]CO(2) fixation. Reaction of [(11)C]CO(2) with 4-methoxybenzylamine in the presence of a CO(2) fixating base was followed by dehydration with POCl(3) and addition of 2-amino-5-nitrothiazole to prepare [(11)C-carbonyl] AR-A014418. This reaction resulted in an 8% uncorrected radiochemical yield, based on [(11)C]CO(2), with high specific activity (4Ci/μmol) within 30min. An in vitro GSK-3β enzyme activity assay revealed that AR-A014418 (K(i)=770nM) is not as potent as previously claimed. The [(11)C]CO(2) fixation methodology described herein should prove generally applicable to preparing 1-aryl-3-benzyl-[(11)C-carbonyl] ureas as radiotracers for positron emission tomography.
|
Authors | Justin W Hicks, Alan A Wilson, Elizabeth A Rubie, James R Woodgett, Sylvain Houle, Neil Vasdev |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 22
Issue 5
Pg. 2099-101
(Mar 01 2012)
ISSN: 1464-3405 [Electronic] England |
PMID | 22321216
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Chemical References |
- Carbon Radioisotopes
- Radiopharmaceuticals
- Thiazoles
- Carbon Dioxide
- N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea
- Urea
- Glycogen Synthase Kinase 3
|
Topics |
- Carbon Dioxide
(chemistry)
- Carbon Radioisotopes
(chemistry)
- Glycogen Synthase Kinase 3
(antagonists & inhibitors, metabolism)
- Humans
- Positron-Emission Tomography
(methods)
- Radiopharmaceuticals
(chemical synthesis, chemistry, pharmacology)
- Thiazoles
(chemical synthesis, chemistry, pharmacology)
- Urea
(analogs & derivatives, chemical synthesis, chemistry, pharmacology)
|